Healthcare provider profile · identity verified

Jason Leep, MD

Family Practice · WHITEFISH, MT · NPI 1811125818

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Quetiapine Fumarate	Quetiapine Fumarate	335	24
Atorvastatin Calcium	Atorvastatin Calcium	301	27
Omeprazole	Omeprazole	251	24
Fluoxetine Hcl	Fluoxetine Hcl	248	13
Famotidine	Famotidine	240	20
Gabapentin	Gabapentin	233	23
Lisinopril	Lisinopril	221	20
Potassium Chloride	Potassium Chloride	219	23
Amlodipine Besylate	Amlodipine Besylate	216	21
Sertraline Hcl	Sertraline Hcl	189	12
Levothyroxine Sodium	Levothyroxine Sodium	181	20
Tamsulosin Hcl	Tamsulosin Hcl	173	18
Furosemide	Furosemide	171	18
Duloxetine Hcl	Duloxetine Hcl	165	11
Eliquis	Apixaban	151	14
Divalproex Sodium	Divalproex Sodium	142	suppressed
Metformin Hcl	Metformin Hcl	140	13
Trazodone Hcl	Trazodone Hcl	135	19
Losartan Potassium	Losartan Potassium	129	15
Venlafaxine Hcl Er	Venlafaxine Hcl	129	suppressed
Torsemide	Torsemide	115	12
Metoprolol Tartrate	Metoprolol Tartrate	107	16
Metoprolol Succinate	Metoprolol Succinate	105	13
Citalopram Hbr	Citalopram Hydrobromide	97	suppressed
Levetiracetam	Levetiracetam	95	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	93	suppressed
Spironolactone	Spironolactone	93	11
Pantoprazole Sodium	Pantoprazole Sodium	89	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	21
Oxycodone Hcl	Oxycodone Hcl	83	20
Oxybutynin Chloride	Oxybutynin Chloride	81	suppressed
Tizanidine Hcl	Tizanidine Hcl	77	suppressed
Montelukast Sodium	Montelukast Sodium	73	suppressed
Ibuprofen	Ibuprofen	72	16
Warfarin Sodium	Warfarin Sodium	71	suppressed
Donepezil Hcl	Donepezil Hcl	70	suppressed
Propranolol Hcl	Propranolol Hcl	67	suppressed
Alendronate Sodium	Alendronate Sodium	66	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	66	suppressed
Simvastatin	Simvastatin	62	suppressed
Aripiprazole	Aripiprazole	60	suppressed
Bupropion Xl	Bupropion Hcl	58	suppressed
Lamotrigine	Lamotrigine	56	suppressed
Methenamine Hippurate	Methenamine Hippurate	56	suppressed
Pravastatin Sodium	Pravastatin Sodium	56	suppressed
Topiramate	Topiramate	54	suppressed
Haloperidol	Haloperidol	52	suppressed
Chlorthalidone	Chlorthalidone	51	suppressed
Carvedilol	Carvedilol	50	suppressed
Tramadol Hcl	Tramadol Hcl	50	11
Baclofen	Baclofen	48	suppressed
Ondansetron Hcl	Ondansetron Hcl	48	14
Mirtazapine	Mirtazapine	47	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	40	suppressed
Clonazepam	Clonazepam	40	suppressed
Meloxicam	Meloxicam	40	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	39	14
Xifaxan	Rifaximin	39	suppressed
Lorazepam	Lorazepam	38	16
Olanzapine	Olanzapine	37	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	37	suppressed
Lactulose	Lactulose	36	suppressed
Cephalexin	Cephalexin	35	suppressed
Digoxin	Digoxin	34	suppressed
Benazepril Hcl	Benazepril Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Prednisone	Prednisone	31	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	31	suppressed
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Pregabalin	Pregabalin	28	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	27	suppressed
Myrbetriq	Mirabegron	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Lithium Carbonate	Lithium Carbonate	26	suppressed
Methocarbamol	Methocarbamol	26	suppressed
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Vilazodone Hcl	Vilazodone Hcl	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Perphenazine	Perphenazine	21	suppressed
Solifenacin Succinate	Solifenacin Succinate	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Glatopa	Glatiramer Acetate	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Morphine Sulfate	Morphine Sulfate	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Risperidone	Risperidone	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Entacapone	Entacapone	18	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	18	suppressed
Primidone	Primidone	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	11
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Finasteride	Finasteride	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Albuterol Sulfate	Albuterol Sulfate	15	suppressed
Calcium Acetate	Calcium Acetate	15	suppressed
Azithromycin	Azithromycin	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Nystatin	Nystatin	14	12
Alprazolam	Alprazolam	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Amantadine	Amantadine Hcl	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Atenolol	Atenolol	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Cyclosporine Modified	Cyclosporine, Modified	11	suppressed
Glatiramer Acetate	Glatiramer Acetate	11	suppressed
Riluzole	Riluzole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error